These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24295130)

  • 41. Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome.
    Zaja F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Salmaso F; Mariuzzi L; Di Loreto C; Baccarani M
    Haematologica; 1997; 82(2):171-7. PubMed ID: 9175321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of surgical management in primary small bowel lymphoma: A single-center experience.
    Hong YW; Kuo IM; Liu YY; Yeh TS
    Eur J Surg Oncol; 2017 Oct; 43(10):1886-1893. PubMed ID: 28751057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients.
    Zinzani PL; Pellegrini C; Broccoli A; Gandolfi L; Stefoni V; Casadei B; Maglie R; Argnani L; Pileri S
    Hematol Oncol; 2015 Sep; 33(3):141-6. PubMed ID: 24986783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas.
    Pan D; Qin J; Farber C; O'Brien J; Filippa D; Portlock CS
    Leuk Lymphoma; 2003 Jun; 44(6):967-71. PubMed ID: 12854895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
    Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
    Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma.
    Oh SY; Ryoo BY; Kim WS; Kim K; Lee J; Kim HJ; Kwon JM; Lee HR; Ko YH; Oh SJ; Park KW; Kim HJ; Kwon HC; Nam E; Kim JH; Park YH; Lee SS; Kim HY; Park K
    Ann Hematol; 2006 Nov; 85(11):781-6. PubMed ID: 16847665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiotherapy of indolent orbital lymphomas : Two radiation concepts.
    König L; Stade R; Rieber J; Debus J; Herfarth K
    Strahlenther Onkol; 2016 Jun; 192(6):414-21. PubMed ID: 27160291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary lymphoma of bone.
    Chin HW; McGuire MH; Block M; Frank AR; Boman BM; Mailliard JA
    Nebr Med J; 1990 Nov; 75(11):303-6. PubMed ID: 2259387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
    Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
    Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The incidence of imaging findings, and the distribution of skeletal lymphoma in a consecutive patient population seen over 5 years.
    Kirsch J; Ilaslan H; Bauer TW; Sundaram M
    Skeletal Radiol; 2006 Aug; 35(8):590-4. PubMed ID: 16547747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma.
    Fernández de Larrea C; Martínez-Pozo A; Mercadal S; García A; Gutierrez-García G; Valera A; Ghita G; Colomo L; Gainza E; Villamor N; Nomdedeu B; Estrach T; Montserrat E; Campo E; López-Guillermo A
    Br J Haematol; 2011 May; 153(3):334-40. PubMed ID: 21375524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
    Sehn LH; Scott DW; Chhanabhai M; Berry B; Ruskova A; Berkahn L; Connors JM; Gascoyne RD
    J Clin Oncol; 2011 Apr; 29(11):1452-7. PubMed ID: 21383296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group.
    Huang JZ; Weisenburger DD; Vose JM; Greiner TC; Aoun P; Chan WC; Lynch JC; Bierman PJ; Armitage JO;
    Leuk Lymphoma; 2003 Nov; 44(11):1903-10. PubMed ID: 14738141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence of time-dependent prognostic factors predicting early death but not long-term outcome in primary CNS lymphoma: a study of 91 patients.
    Ghesquières H; Drouet Y; Sunyach MP; Sebban C; Chassagne-Clement C; Jouanneau E; Honnorat J; Biron P; Blay JY
    Hematol Oncol; 2013 Jun; 31(2):57-64. PubMed ID: 22886543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical Features, Treatment and Prognostic Factors of 94 Patients with Follicular Lymphoma].
    DU XY; Hu K; Zhao W; Yang P; Wan W; Jing HM; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):756-764. PubMed ID: 29950216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nongastric marginal zone B-cell lymphoma: analysis of 247 cases.
    Oh SY; Ryoo BY; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Kim HJ; Kwon HC; Bang SM; Kim JH; Park J; Lee SS; Kim HY; Park K
    Am J Hematol; 2007 Jun; 82(6):446-52. PubMed ID: 17266060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
    Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
    Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.